Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
G. Tridente, Martin Raithel, Leonard B. Weinstock, H.-J. Hertfelder, Franz Ludwig Dumoulin, Jürgen Homann, G. J. Qagish, Gerhard J. Molderings, J. Textor, V. S. Schäfer, R. Barion, D. Klingmüller, Lawrence B. Afrin, B. Sido, D. Berdel, M. Mücke
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology
Omalizumab is an effective therapeutic humanized murine IgE antibody in many cases of primary systemic mast cell activation disease (MCAD). The present study should enable the clinician to recognize when treatment of MCAD with omalizumab is contraind